Barinthus Biotherapeutics (BRNS) Other Operating Expenses (2022 - 2025)
Barinthus Biotherapeutics (BRNS) reported Other Operating Expenses of $4.7 million for Q3 2025, down 61.77% quarter-over-quarter from $12.2 million in Q4 2024.
Barinthus Biotherapeutics (BRNS) Other Operating Expenses (2022 - 2025) Analysis & Trends
Barinthus Biotherapeutics has reported Other Operating Expenses for 3 years, with the latest figure at $4.7 million in Q3 2025.
- For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (down 61.77% YoY), and the FY2025 full-year result was $4.7 million, down 61.77% from the prior year.
- Other Operating Expenses for Q3 2025 stood at $4.7 million, down from $12.2 million in the prior quarter.
- The five-year high for Other Operating Expenses was $19.4 million in Q4 2022, with the low at -$10.8 million in Q3 2022.
- Historically, Other Operating Expenses has averaged $3.9 million across 3 years, with a median of $4.7 million in 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.67 Mn |
| Dec 31, 2024 | 12.21 Mn |
| Dec 31, 2022 | 19.37 Mn |
| Sep 30, 2022 | -10.82 Mn |
| Jun 30, 2022 | -5.89 Mn |